COMMUNIQUÉS West-GlobeNewswire

Bioblast Pharma Ltd. Announces Entry Into Merger Agreement to Acquire Enlivex Therapeutics Ltd. to Advance Clinical Stage Immunotherapeutic Drug Pipeline for the Treatment of Life-Threatening Diseases Sepsis, GvHD and Solid Tumors
19/11/2018
Enlivex Therapeutics is a private, venture-funded clinical stage immunotherapy company developing an allogeneic drug pipeline for immune system rebalancing, which is critical for the treatment of life-threatening immune [...]
Rubius Therapeutics to Present at Evercore ISI HealthCONx Conference
19/11/2018
CAMBRIDGE, Mass., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biotechnology company developing an entirely new class of allogeneic cellular therapies, announced today that Pablo J. [...]
K2M Group Holdings, Inc. Announces Fundamental Change With Respect to its 3.00% Convertible Senior Notes due 2025 and 4.125% Convertible Senior Notes due 2036
19/11/2018
LEESBURG, Va., Nov. 19, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (“K2M”) today announced that, in connection with the closing of its merger with a subsidiary of Stryker Corporation (NYSE:SYK), a “Fundamental [...]
Guardant Health Reports Third Quarter 2018 Financial Results
19/11/2018
Revenue growth of 95% over prior year period REDWOOD CITY, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally [...]
Scholar Rock Announces the Addition of Edward (Ted) Myles to Its Board of Directors
19/11/2018
CAMBRIDGE, Mass., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on EPIDIOLEX® (cannabidiol) Oral Solution at the American Epilepsy Society Annual Meeting
19/11/2018
Meeting Highlights Include over 20 Posters and Virtual Tour of the Epidiolex Manufacturing Process LONDON and CARLSBAD, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company [...]
Wright Medical Group N.V. to Present at BMO Prescriptions for Success Healthcare Conference
19/11/2018
Wednesday, December 12, 2018 at 8:40 a.m. Eastern Time AMSTERDAM, The Netherlands, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) announced today that it will present at the BMO Prescriptions [...]
BELLUS Health Announces Positive Top-Line Phase 1 Results for its Chronic Cough Drug Candidate BLU-5937
19/11/2018
- No Taste Loss at the Anticipated Therapeutic Doses - - BLU-5937 is Shown to be Safe and Well Tolerated - - Company Intends to Initiate a Clinical Phase 2 Study in Mid-2019; Top-line Results Expected in Mid-2020 - - [...]
BELLUS Santé annonce les résultats positifs principaux de l’étude de phase 1 pour le BLU-5937, son médicament candidat phare pour le traitement de la toux chronique
19/11/2018
BELLUS Santé annonce les résultats positifs principaux de l’étude de phase 1 pour le BLU-5937, son médicament candidat phare pour le traitement de la toux chronique - Aucune perte du goût aux doses thérapeutiques [...]
DeLibra Wesley Named to the SIA List, Global Power 150 – Women in Staffing 2018
19/11/2018
The list recognizes female leadership and contributions to the global staffing industry DALLAS, Nov. 19, 2018 (GLOBE NEWSWIRE) -- The Delta Companies (TDC), a leading staffing firm for healthcare professionals [...]
GEn1E Lifesciences Adds to Development Pipeline with Exclusive Option to License University of Maryland, Baltimore’s MUC1-Ecto-Domain Anti-Bacterial Agent
19/11/2018
Provides GEn1E the potential to enter clinic with a therapy for Pseudomonas infections in Cystic Fibrosis patients PALO ALTO, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- GEn1E Lifesciences Inc. (“GEn1E”), a pre-clinical [...]
Sanofi: Disclosure of trading in own shares
19/11/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
19/11/2018
Pièce jointe Reporting FR.pdf
SuperSonic Imagine Spotlights Groundbreaking Aixplorer® MACH 30 Platform at RSNA 2018
19/11/2018
A sleek, intuitive new platform ready for AI, Aixplorer MACH 30 has all the assets to address the United States’ market for today and in the future AIX-EN-PROVENCE, France, Nov. 19, 2018 (GLOBE NEWSWIRE) -- SuperSonic [...]
InMed of Coral Springs Implements eRAD RIS and Speech Recognition
19/11/2018
Customer expands its platform to reap benefits of integration GREENVILLE, S.C., Nov. 19, 2018 (GLOBE NEWSWIRE) -- InMed Diagnostic of Coral Springs, FL, a multi-modality imaging provider in South Florida, has deployed [...]
Ossur Hf :Transactions in relation to share buyback program
19/11/2018
Announcement no. 67/2018 19 November 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Replacement CT Tube Solutions from Richardson Healthcare at RSNA 2018
19/11/2018
Stop by Booth 7330 to see the ALTA750™ CT Tube LAFOX, Ill., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Richardson Healthcare , a Division of Richardson Electronics, Ltd. (NASDAQ: RELL), will be displaying the ALTA750 replacement [...]
UPDATE -- Cellworks to Present 10 Abstracts at 2018 American Society of Hematology Annual Meeting
19/11/2018
ASH Abstracts Reveal How AI-Driven Biosimulation Technology Predicts Drug Response in Individual Cancer Patients with High Accuracy SAN JOSE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in [...]
Cellworks to Present 10 Abstracts at 2019 American Society of Hematology Annual Meeting
19/11/2018
ASH Abstracts Reveal How AI-Driven Biosimulation Technology Predicts Drug Response in Individual Cancer Patients with High Accuracy SAN JOSE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in [...]

Pages